Month: September 2020

NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH IT WOULD BE UNLAWFUL TO DO SO. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.IMCD successfully raises EUR 400 million through an accelerated bookbuild offering of new sharesROTTERDAM, The Netherlands (16 September 2020, 07:45 CET) – IMCD N.V. (“IMCD” or the “Company”), a leading distributor of speciality chemicals and food ingredients, announces that it has successfully raised approximately EUR 400 million through an accelerated bookbuild offering (the “Offering”) of 4,395,604 newly issued ordinary shares at an offer price of EUR 91.00 per ordinary share. The net proceeds of the Offering will be used by the Company for general...

Stockholm, Sweden – Sinch AB (publ) – XSTO: SINCHSinch AB (publ), a global leader in cloud communications and software for mobile operators, has been selected by Valor Agregado Digital, S.A. de C.V. (VADSA) to provide key real-time charging capabilities for one of the most ambitious MVNO projects in Mexico.With the VADSA partnership, Sinch’s platform will be integrated into Mexico’s innovative Red Compartida shared 4G-LTE network. The Red Compartida initiative has been lauded internationally as a shining example of sparking competition in the telecommunication marketplace for the benefit of subscribers. Sinch’s first deployment on the network will serve customers on Exis Telecom, VADSA’s fully digital MVNO.In a market where voice services make up a significant share of the ARPU, VADSA will use key components of Sinch’s charging...

BW Energy is presenting at the Pareto Securities’ Energy Conference today. Please see the attached presentation.The presentation references the progression of an alternative development plan for Hibiscus/Ruche, utilising a converted jack-up instead of constructing and installing a new wellhead platform. The conversion concept is expected to reduce development capex, time to first oil and enable a substantial reduction to field-development related climate gas emissions by re-using already existing energy infrastructure.The alternative development plan has the potential to lower the estimated cash-break even oil price for the Hibiscus/Ruche (phase 1 and 2) development to approximately USD 25 per barrel Brent. A final decision to restart the Hibiscus/Ruche development is subject to lifting of COVID-19 restrictions to allow for efficient...

BW Offshore is presenting at the Pareto Securities’ Energy Conference today. Please see the attached presentation.For further information, please contact:Ståle Andreassen, CFO, +65 97 27 86 47Anders S. Platou, Head of Corporate Finance, +47 99 50 47 40IR@bwoffshore.comAbout BW Offshore:BW Offshore is a leading provider of floating production services to the oil and gas industry. The company also participates in developing proven offshore hydrocarbon reservoirs. BW Offshore is represented in all major oil and gas regions world-wide with a fleet of 15 owned FPSOs. The company has more than 35 years of production track record, having executed 40 FPSO and FSO projects. BW Offshore is listed on the Oslo Stock Exchange.This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading...

India, 14 September 2020 GSTR-2B is an auto-populated ITC statement generated for every GST registered taxpayer. The data in this return is populated from the GSTR-1, GSTR-5 (filed by non-resident taxable person) and G STR-6 (filed by an Input Service Distributor ‘ISD’) filed by the taxpayer’s suppliers. Interestingly, the GST portal has just released the Matching Offline Tool v1.0. Through this tool, the taxpayer can download the GSTR-2B and match it with the purchase register. This GSTR-2B is a static statement that will be available once a month, on the 12th. The taxpayers can view this on their dashboard through the GST Portal. On the other hand, by downloading the Matching Offline Tool, the taxpayer can download the auto-drafted Input Tax Credit (ITC) statement – GSTR-2B and view it through the offline tool. Furthermore, this...

Next-generation biomarker cytology test supports World Health Organization’s goal to eliminate cervical cancer, which is nearly 100 percent preventable with proper screening, vaccination and treatmentNew indication allows this first FDA-approved biomarker-based test to be used as triage for positive cobas HPV tests run on cobas 6800/8800 Systems in primary screening or co-testing programsMore sensitive than traditional Pap cytology, this test allows clinicians to determine which HPV-positive women require further diagnostic procedures to prevent disease progressionBasel, 16 September 2020 — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval for the expanded use of CINtec® PLUS Cytology, the first triage test based on biomarker technology for women whose cervical cancer screening results...

Schlieren/Switzerland, 16 September 2020The news release can be downloaded from the following link:AttachmentRelease_20200916

Orphazyme A/SCompany announcement                                                                                       No. 50/2020                                                                                                          Company Registration No. 32266355If approved, arimoclomol would become the first approved therapy in the U.S. for people with Niemann-Pick disease Type C (NPC)FDA has set target PDUFA action date of March 17, 2021Copenhagen, Denmark, September 16, 2020 – Orphazyme A/S (ORPHA.CO), a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted, with Priority Review, the company’s New Drug Application (NDA) for arimoclomol for the treatment of NPC.The FDA...

NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) — StepStone Group Inc. (“StepStone”) today announced the pricing of its initial public offering of 17,500,000 shares of its Class A common stock at a public offering price of $18.00 per share. The shares are expected to begin trading on the Nasdaq Global Select Market on September 16, 2020 under the ticker symbol “STEP.”In addition, StepStone has granted the underwriters a 30-day option to purchase up to an additional 2,625,000 shares of its Class A common stock at the initial public offering price, less underwriting discounts and commissions. The offering is expected to close on or about September 18, 2020 subject to satisfaction of customary closing conditions.J.P. Morgan, Goldman Sachs and Morgan Stanley are acting as joint book-running managers for the offering. Barclays and UBS Investment...

SUWON, Korea, Sept. 15, 2020 (GLOBE NEWSWIRE) — OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today presented a poster at the TIDES: Oligonucleotides and Peptide Therapeutics 2020 Virtual Conference. The presentation entitled, “Asymmetric siRNA Therapeutics by OliX Pharmaceuticals,” highlights OliX’ proprietary asiRNA platform technology along with the preclinical/clinical development of various programs.The Company presented the clinical development status of OLX101A, a cell-penetrating asymmetric siRNA (cp-asiRNA) targeting hypertrophic and keloid scars. OliX also presented data on ophthalmic pipelines that demonstrate the efficacy of OLX301A, targeting wet and dry age-related macular degeneration (AMD) in rodents and non-human primate disease models. In addition, OLX301D, targeting subretinal...